?
Pitofsky Jason
VP Controller
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK
2009236
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
4,691
Price per Share :
$703.43
Equivalence :
$3,299,790.13
Transaction History
-
M4,691 Shares After TransactionValue : $1,747,209.86$181,388.02Transaction Date : 08/07/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
S4,204 Shares After TransactionValue : $4,498,280.00Sold $521,090.00Transaction Date : 08/07/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
A5,111 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/06/24
-
Footnotes
-
-
Footnotes:#1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
-
F4,962 Shares After TransactionValue : $3,905,094.00$117,263.00Transaction Date : 12/09/24
-
Footnotes
-
-
Footnotes:#1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
-
G89 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/04/24
-
Footnotes
-
-
Footnotes:#1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.